HUMX Stock Overview
Human Xtensions Ltd. develops, manufactures, markets and sells a modular medical device for minimally invasive surgical operations.
Capture your thoughts, links and company narrative
Human Xtensions Ltd. Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||₪1.70|
|52 Week High||₪4.40|
|52 Week Low||₪0.65|
|1 Month Change||53.70%|
|3 Month Change||67.12%|
|1 Year Change||-17.85%|
|3 Year Change||n/a|
|5 Year Change||n/a|
|Change since IPO||-93.15%|
Recent News & Updates
Is Human Xtensions (TLV:HUMX) In A Good Position To Deliver On Growth Plans?Aug 12
Is Human Xtensions (TLV:HUMX) In A Good Position To Deliver On Growth Plans?Mar 25
Here's Why We're Not Too Worried About Human Xtensions' (TLV:HUMX) Cash Burn SituationOct 21
We Think Human Xtensions (TLV:HUMX) Can Afford To Drive Business GrowthMay 03
What Type Of Shareholders Own The Most Number of Human Xtensions Ltd. (TLV:HUMX) Shares?Mar 03
|HUMX||IL Medical Equipment||IL Market|
Return vs Industry: HUMX exceeded the IL Medical Equipment industry which returned -48.6% over the past year.
Return vs Market: HUMX matched the IL Market which returned -17.4% over the past year.
|HUMX Average Weekly Movement||17.5%|
|Medical Equipment Industry Average Movement||6.9%|
|Market Average Movement||5.2%|
|10% most volatile stocks in IL Market||8.6%|
|10% least volatile stocks in IL Market||3.7%|
Stable Share Price: HUMX is more volatile than 90% of IL stocks over the past 3 months, typically moving +/- 18% a week.
Volatility Over Time: HUMX's weekly volatility (18%) has been stable over the past year, but is still higher than 75% of IL stocks.
About the Company
Human Xtensions Ltd. develops, manufactures, markets and sells a modular medical device for minimally invasive surgical operations. It offers HandX, a handheld electromechanical device for use in laparoscopic procedures; Fenestrated Grasper; Monopolar Hook; and Needle Holder. The company was incorporated in 2012 and is based in Netanya, Israel.
Human Xtensions Ltd. Fundamentals Summary
|HUMX fundamental statistics|
Is HUMX overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|HUMX income statement (TTM)|
|Cost of Revenue||₪747.00k|
Last Reported Earnings
Dec 31, 2022
Next Earnings Date
|Earnings per share (EPS)||-1.67|
|Net Profit Margin||-1,405.36%|
How did HUMX perform over the long term?See historical performance and comparison